We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$947M
AUM Growth
+$67.9M
Cap. Flow
-$19M
Cap. Flow %
-2.01%
Top 10 Hldgs %
31.65%
Holding
277
New
24
Increased
72
Reduced
85
Closed
14

Top Buys

Rank Stock Value
1
COL
Rockwell Collins
COL
+$10.4M
2
LTM
LIFE TIME FITNESS INC
LTM
+$10.1M
3
VMI icon
Valmont Industries
VMI
+$7.73M
4
DAR icon
Darling Ingredients
DAR
+$6.27M
5
PERY
Perry Ellis International Inc
PERY
+$1.66M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$16.1M
2
EXC icon
Exelon
EXC
+$6.81M
3
CROX icon
Crocs
CROX
+$5.78M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.63M
5
AVY icon
Avery Dennison
AVY
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Industrials 17.97%
3 Healthcare 12.8%
4 Consumer Discretionary 12.43%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPT
151
Franklin Premier Income Trust
PPT
$323M
$606K 0.06%
111,500
+3,500
+3% +$18.8K
CDE icon
152
Coeur Mining
CDE
$15.8B
$604K 0.06%
55,675
+17,200
+45% +$194K
ELV icon
153
Elevance Health
ELV
$82.1B
$591K 0.06%
6,400
– –
XBI icon
154
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$585K 0.06%
13,500
-2,100
-13% -$86.9K
ORI icon
155
Old Republic International
ORI
$10.5B
$569K 0.06%
32,975
-2,875
-8% -$47.2K
RTX icon
156
RTX Corp
RTX
$294B
$569K 0.06%
7,945
+3,178
+67% +$217K
CRR
157
DELISTED
Carbo Ceramics Inc.
CRR
$568K 0.06%
4,875
-300
-6% -$34.1K
CROX icon
158
Crocs
CROX
$6.69B
$557K 0.06%
35,025
-434,350
-93% -$5.78M
ANDV
159
DELISTED
Andeavor
ANDV
$555K 0.06%
9,500
-300
-3% -$15.6K
MJN
160
DELISTED
Mead Johnson Nutrition Company
MJN
$552K 0.06%
6,600
– –
SKX
161
DELISTED
Skechers
SKX
$543K 0.06%
49,200
-24,555
-33% -$256K
ORBK
162
DELISTED
Orbotech Ltd
ORBK
$505K 0.05%
37,400
+15,000
+67% +$191K
PG icon
163
Procter & Gamble
PG
$346B
$492K 0.05%
+6,045
New +$492K
PFL
164
PIMCO Income Strategy Fund
PFL
$383M
$474K 0.05%
41,950
+500
+1% +$5.77K
PM icon
165
Philip Morris
PM
$305B
$474K 0.05%
+5,450
New +$476K
MERC icon
166
Mercer International
MERC
$44.7M
$473K 0.05%
47,500
-1,000
-2% -$8.92K
SYY icon
167
Sysco
SYY
$40.2B
$469K 0.05%
13,000
-3,900
-23% -$132K
VE
168
DELISTED
VEOLIA ENVIRONNEMENT
VE
$468K 0.05%
28,650
-400
-1% -$6.71K
WBA
169
DELISTED
Walgreens Boots Alliance
WBA
$459K 0.05%
8,000
– –
VTN icon
170
Invesco Trust for Investment Grade New York Municipals
VTN
$162M
$444K 0.05%
34,000
+2,500
+8% +$33.5K
SLB icon
171
SLB Ltd
SLB
$76.5B
$438K 0.05%
4,870
– –
UNP icon
172
Union Pacific
UNP
$178B
$436K 0.05%
5,200
+2,000
+63% +$158K
OPK icon
173
Opko Health
OPK
$936M
$435K 0.05%
51,600
+28,800
+126% +$291K
RAND icon
174
Rand Capital
RAND
$29.9M
$416K 0.04%
14,811
+593
+4% +$15.8K
BNY
175
Bank of New York Mellon
BNY
$107B
$412K 0.04%
11,800
-5,500
-32% -$179K
5 6
7
8 9

Similar funds

SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return
AAIM
American Assets Investment Management San Diego, California $1.47B AUM 43% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return

Shufro Rose & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Shufro Rose & Co held 277 positions worth $947M, up 7.7% from $879M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Shufro Rose & Co's Q4 2013 filing shows 24 new, 72 increased, 85 reduced and 14 closed positions. Its largest new stake was Rockwell Collins: 145,705 shares worth $10.8M. The largest sale was Teva Pharmaceuticals, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q4 2013 buy was Rockwell Collins: 145,705 shares worth $10.8M.
  • Shufro Rose & Co added most to Vishay Precision Group in Q4 2013, an estimated $1.63M increase.
  • Shufro Rose & Co's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $16.1M.
  • Shufro Rose & Co fully exited MAIDENFORM BRANDS, INC in Q4 2013, selling an estimated $4.49M.
  • Shufro Rose & Co's ten largest holdings make up 32% of its $947M portfolio in Q4 2013.
  • Shufro Rose & Co opened 24 new positions and closed 14 in Q4 2013.
  • Shufro Rose & Co's portfolio value rose 7.7% quarter-over-quarter to $947M.

Based on Shufro Rose & Co's 13F filing for Q4 2013, filed 4 Feb 2014.